Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and would not recommend the drug coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.

    SOTU: Biden Promises Fentanyl Crackdowns, OUD Meds in Prisons

    On February 7, President Joe Biden delivered the State of the Union address before ...

    DOJ Delays Safehouse Response to 2023, an Unexpected Blow

    The Department of Justice was expected to filed its long-awaited response to the ongoing ...

    Four States Close Prison Slavery Loopholes; Louisiana Votes Against

    Alabama, Oregon, Tennessee and Vermont have closed loopholes in their state constitutions that had ...

    FDA Exempts Harm Reduction From Biggest Naloxone Access Restrictions

    On September 22, the Food and Drug Administration announced that harm reduction naloxone suppliers ...

    “Rainbow Fentanyl” Is Probably a Good Thing, at This Point

    When Toronto’s Moss Park Overdose Prevention Site opened as an unsanctioned service in August ...

    The Pfizer Naloxone Shortage Ends, Leaving Us With Just the Regular One

    [Read Filter‘s August 1 story introducing Remedy Alliance’s naloxone distribution here.]   In the ...

    Exclusive: For the First Time, Harm Reduction Gets a Naloxone of Its Own

    In late April 2021, a manufacturing disruption brought Pfizer’s naloxone production to a standstill, ...

    DULF Keeps Distributing Checked Drugs as Health Canada Flags Denial

    On May 4 in Vancouver’s Downtown Eastside, the Drug User Liberation Front (DULF) distributed ...